SynAct Pharma AB (STO: SYNACT)
Sweden
· Delayed Price · Currency is SEK 9.33
+0.07 (0.70%)
Nov 22, 2024, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 385.30 million as of November 22, 2024. Its market cap has increased by 52.56% in one year.
Market Cap
385.30M
Enterprise Value
348.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.33
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 385.30M, an increase of 504.37%. That is a compound annual growth rate of 24.00%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,158.07B |
| Swedish Orphan Biovitrum AB (publ) | 99.53B |
| Sectra AB (publ) | 52.53B |
| Getinge AB (publ) | 45.40B |
| Camurus AB (publ) | 32.34B |
| Vitrolife AB (publ) | 28.41B |
| Medicover AB (publ) | 26.03B |
| Elekta AB (publ) | 23.73B |